Treatment of Relapsed/Refractory Myeloma (excluding T-cell redirection therapy)
Subcutaneous administration of isatuximab by an on-body delivery system (OBDS) in multiple myeloma patients: results of a nurse survey
Nuria Sanchez Avello, RN (she/her/hers)
Enfermera Coordinadora
EnfermerĂa de la Unidad de Ensayos ClĂnicos Valdecilla, Santander, Spain
Santander, Spain